Hamamoto, Yasuo https://orcid.org/0000-0002-5737-122X
Inagawa, Akihiko
Yamamoto, Tsunehisa
Ito, Hiroaki
Matsumoto, Hiroki https://orcid.org/0000-0003-4313-8125
Article History
Received: 2 December 2024
Accepted: 23 June 2025
First Online: 21 July 2025
Declarations
:
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.
: Dr. Yasuo Hamamoto has received consulting fees from Ono Pharmaceutical Co., Ltd., and Bristol Myers Squibb K. K. Akihiko Inagawa and Hiroki Matsumoto are employees of Ono Pharmaceutical Co., Ltd. Tsunehisa Yamamoto and Hiroaki Ito are employees of Bristol Myers Squibb K. K.
: Written informed consent was obtained from participants to participate in the study.